MTOR and thyroid gland carcinoma: The conclusion found by Han et al. that metformin may inhibit the growth, migration and epithelial–mesenchymal transition (EMT) of thyroid cancer cell lines through mTOR pathway other than insulin pathway is also consistent with the above findings [14].